Researchers from Charité – Universitätsmedizin Berlin and the Zuse Institute Berlin have developed a new generation of pain medications.
The researchers used computer simulations to develop new opioids that will only work at sites affected by injury or inflammation. These drugs can prevent the occurrence of brain- and gut-related side effects typically associated with conventional opioids and have been shown to be successful in preclinical studies. Results from this research have been published in Pain* and Scientific Reports**.
Opioids are a class of drugs with powerful pain-relieving properties. They are mainly used to treat the pain associated with tissue damage and inflammation, such as that caused by surgery or cancer. Common side effects associated with their use include drowsiness, nausea, constipation, dependency and, in some cases, respiratory arrest. The research team, which is led by Prof. Dr. Christoph Stein of the Department of Anesthesiology and Surgical Intensive Care Medicine on Campus Benjamin Franklin, are hoping to develop new types of pain medications which will work without producing dangerous side effects. Collaborating with PD Dr. Marcus Weber of the Zuse Institute Berlin, the researchers used computer simulations to develop two new opioids. In both cases, the researchers used fentanyl as the starting molecule.
The researchers hypothesized that tissues which are damaged or inflamed show stronger interaction between ‘opioid agonists’ – the substances that elicit the pain-relieving effect – and the opioid receptors they bind to. Their computer simulations suggested that this is due to an increased concentration of protons in inflamed tissues, which leads to lower pH values than in healthy tissues, resulting in acidic conditions. Opioid molecules need to undergo protonation before they can bind to and activate opioid receptors. The researchers used this knowledge to design two drugs that would only exist in their protonated state in the presence of inflammation. This restricts opioid receptor activation to sites of tissue damage or inflammation, rather than receptors in the brain or gut.
“Our innovative design method provides a robust basis for a new generation of pain medications,” reports Prof. Stein. He adds: “These drugs could help us both to avoid the dangerous side effects of conventional opioids and to reduce complications. They would also help us stem the opioid crisis, a problem that is particularly evident in the United States.”
The researchers hope to further develop these newly-designed drugs in order to make them available to patients. They also plan to enhance their understanding of the molecular processes underlying the complex interactions seen in inflamed tissues, in the hope that they may be able to support opioid optimization through the insights they gain. Ideally, their insights will also be beneficial for other drugs, such as those used to treat high blood pressure.
The Latest on: Pain medications
via Google News
The Latest on: Pain medications
- Interdisciplinary Pain Management Approach May Reduce Opioid and Benzodiazepine Use in Chronic Pain Patients on February 21, 2019 at 3:26 am
Combined use of opioids and benzodiazepine, two widely used classes of medication for pain management, greatly increases the potential risk for abuse and overdose. Researchers at Midwestern University ... […]
- Smokers Are At High Risk for Low Back Pain, Hospitalization and Opioid Use on February 21, 2019 at 3:26 am
and physicians should ask these patients about other comorbidities that may make their pain treatment more difficult, according to a new study presented this week at the Association of Academic Physia... […]
- Zosano Announces Completion of the Final Milestone in the Long-Term Safety Study of Qtrypta™ for the Acute Treatment of Migraine Disease on February 21, 2019 at 3:00 am
Qtrypta showed robust and rapid relief of migraine pain, an effect that was consistent throughout the chronic treatment period NDA submission expected in Q4 2019 for the first intracutaneous ... […]
- Sex at what price? Insurers often won't cover drugs to treat problems on February 21, 2019 at 2:00 am
That enabled her to have sex without pain. Her husband's employer plan covered the medication, and her copayment was about $100 every other month. However, after she enrolled in Medicare, her Part D p... […]
- Irish Woman Cuts Off Her Own Finger in Search of Relief From Chronic Pain on February 20, 2019 at 5:35 pm
Chronic pain conditions are, by definition, lifelong. While there are various medications and treatments that may provide some relief, there is no “one-size-fits-all” treatment option guaranteed to he... […]
- 2018 Upper Back Pain Treatment "Highlight Reel" Released on February 20, 2019 at 9:31 am
The highlight reel is composed of short snippets from each of the satisfied patient’s featured on it. The complete individual testimonial videos from each of the ten patients are all available ... […]
- VT Bill Would Direct Providers To Follow Pain Medication Guidelines on February 19, 2019 at 4:59 am
A bill has been proposed in the Vermont House to make sure that health care providers follow guidelines for prescribing opioid pain medications to reduce the risk of a patient becoming addicted. A lea... […]
- Pet Pain Management Drugs Market to witness astonishing growthoehringer Ingelheim, Zoetis, Merck Animal Health, Bayer on February 19, 2019 at 1:16 am
Feb 19, 2019 (Heraldkeeper via COMTEX) -- HTF MI released a new market study on Global Pet Pain Management Drugs Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages an... […]
- Back pain? A physiotherapist may offer the most effective treatment, if you can afford it on February 14, 2019 at 5:18 am
Back pain is a common and costly health problem. It is the leading cause of disability worldwide and a "call to action" recently published in The Lancet highlights the risks of over-medicalization ... […]
via Bing News